PipelinePharma Logo

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Irinotecan manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

irinotecan

Solution for injection 40 mg/2 ml, 100 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Registered in
Chile , Cyprus , Dominican Republic , Ecuador , El Salvador , Ethiopia , Guatemala , Indonesia , Iraq , Israel , Kuwait , Malaysia , Mexico , Moldova , Morocco , Myanmar , Nicaragua , Panama , Paraguay , Peru , Philippines , Palestinian Territory , Senegal , Sri Lanka , Thailand , Trinidad And Tobago , Uganda , Ukraine , Venezuela , Vietnam , Yemen
Available for
Licensing with supply, Distribution only
Manufacturer #8924
This European pharmaceutical company specializes in manufacturing a range of products including prescription medications, over-the-counter drugs, and medical devices. They possess a strong research focus with a GLP accredited research unit driving innovation in the sector. The company holds GMP certifications and boasts an extensive portfolio protected by patents. Key therapy areas include oncology and anti-infective treatments, with principal dosage forms including vials and tablets. They cater to markets across the EU and other regulated regions, emphasizing quality control through rigorous testing and a dedicated packaging facility for specialized products like Cephalosporins and Oncology medications.

Manufacturer usually replies in 14 days

irinotecan

Concentrate for solution for infusion 20 mg/ml - 2 ml, 5 ml, 15 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Available for Balkans only
Manufacturer #17331
This company has been operating in the pharmaceutical industry for over five decades, demonstrating a strong commitment to healthcare solutions. They specialize in manufacturing finished dosage formulations, biosimilars, and API/DC granules, catering to diverse needs within the healthcare market. Their focus on research and development drives innovation and ensures high-quality products, while their commitment to regulatory compliance ensures patient safety and efficacy. They possess extensive experience in the pharmaceutical industry, with a global reach and a strong presence in key regions like Asia and North America. Their production lines are compliant with EU and US GMP standards, reflecting their dedication to quality and adherence to international best practices. Key therapy areas include oncology, cardiology, and other areas where biosimilars are widely used. They offer a variety of dosage forms including solids, liquids, and injectables. While specific product patents are not explicitly mentioned, their focus on innovation and research suggests they actively pursue intellectual property protection for their offerings.

irinotecan

Injection 100 mg/5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

This CTD dossier owner and manufacturer is a leading manufacturer of anti-cancer medications, specializing in a wide range of oncology drugs including those for solid tumors, hematology, and supportive care. They boast a portfolio of over 100 products with a focus on cost-effectiveness through in-house API development and manufacturing. The company's commitment to innovation is evident in their New Drug Delivery System (NDDS) formulations which aim to improve patient compliance and reduce medication waste. Their strong R&D pipeline promises further advancements in the oncology field. They hold WHO-GMP certifications for their API plant, enabling both domestic and international market reach. Key therapy areas include AML, Renal Cell Carcinoma, Gastro-Intestinal tumors, Pancreatic Neuroendocrine Tumors, Thyroid cancer, and Prostate cancer.

Manufacturer usually replies in 33 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the Irinotecan drug?

Irinotecan is an antineoplastic enzyme inhibitor; it reduces the spread of the cancer cells in the body. It is a medication used to treat colon cancer and small cell lung cancer. Irinotecan is usually administered during chemotherapy as a single agent or in combination with other drugs.
The FDA, in the US, approved the medical use of Irinotecan medication in 1996. Irinotecan is on the WHO's List of Essential Medicines, the safest and most effective medicines needed in a health system. The natural compound camptothecin found in the Chineses ornamental tree Camptotheca acuminata is used to make the Irinotecan medication.

Irinotecan manufacturers and wholesalers:

The US brand name for Irinotecan is Camptosar. Irinotecan is a globally found drug. Among all the manufacturers, we can list some, such as Pfizer Inc, Accord Healthcare Inc, Actavis Totowa Llc, Teva Parenteral Medicines Inc, and Watson Laboratories Inc.
Irinotecan suppliers market it in the forms of 20 mg solutions or solutions for injection. Under the generic names, for injection of Irinotecan, the drug can be found at different dosages: 40 mg/2 ml; 100 mg/5 ml; 300 mg/15 ml; 500 mg/25 ml. For Camptosar, the solution for injection can be marketed in the strength of 40 mg/2 ml; 100 mg/5 ml; 300 mg/15 ml.

Irinotecan for sales:

On the US market, the price of Irinotecan can vary if it is sold under the generic name or the brand name. For 20mg/ml of an intravenous solution of Irinotecan, it can cost from $17 to $202 for 2ml, about $19.60 for 5ml, and about $131.30 for 25ml. The prices for Irinotecan under the brand name Camptosar are slightly different. For Camptosar 20 mg/ml intravenous solution, 2 ml costs about $35.60, 5 ml about $48.48, and for 15ml, it costs about $126.43
As Irinotecan is a globally found drug, you may encounter fraudulent online websites that will want to sell Irinotecan with some risks for you and your clients. By using Pipelinepharma B2B marketplace, you avoid time-consuming sourcing, and you directly find qualified sellers of Irinotecan. Those manufacturers and distributors have been through quality control procedures to ensure they were qualified partners. On the online platform, Irinotecan is mostly available from the EU, India, Argentina, Turkey, China, and Ukraine. Thanks to the intuitive online marketplace, you will find Irinotecan and many other drugs quickly and efficiently. Placing an order has never been easier than with Pipelinepharma. Let us connect you with Irinotecan. Manufacturers and distributors.

How to use Irinotecan drugs?

Using Irinotecan medication as a single agent for the treatment of colorectal cancer, an adult should be administered 125 mg/m2 IV over 90 minutes on Days 1, 8, 15, and 22 then 2-week rest or 350 mg/m2 IV over 90 minutes on Day 1 every three weeks.
Taking Irinotecan can cause some side effects, the most common ones are severe diarrhea, black, tarry stools, blood in the urine or stools, blurred vision, changes in skin color, and chest pain or discomfort.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.